Gemcitabine Reverses Cisplatin Resistance: Demonstration of Activity in Platinum- and Multidrug-Resistant Ovarian and Peritoneal Carcinoma

Author： Rose P.G. Mossbruger K. Fusco N. Smrekar M. Eaton S. Rodriguez M.

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.88, Iss.1, 2003-01, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity of Gemcitabine in Platinum-resistant Ovarian Germ Cell Cancer

By Maas K. Daikeler T. Kanz L. Bokemeyer C.

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1437-1438

Elsevier

Access to resources Recommend Favorite

KT-5720 Reverses Multidrug Resistance in Variant S49 Mouse Lymphoma Cells Transduced With the Human MDR1 cDNA and in Human Multidrug-resistant Carcinoma Cells

By Galski H. Lazarovici P. Gottesman M.M. Murakata C. Matsuda Y. Hochman J.

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 380-388

Elsevier

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 35-38

Spandidos Publications

Access to resources Recommend Favorite

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang Wu Xiao-Nan Chen Jie Wang Wen-Xiang Lu ZuFu

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro

Oncology Reports, Vol. 28, Iss. 6, 2012-01 ,pp. : 2023-2028

Spandidos Publications

Access to resources Recommend Favorite